AI assistant
ABBOTT LABORATORIES — Director's Dealing 2004
Aug 3, 2004
29777_dirs_2004-08-03_8f35d686-e8f5-427b-b553-6d9382af8758.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-08-01
Reporting Person: Landgraf John C (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-08-01 | Common shares without par value | A | 3500 | $39.24 | Acquired | 64805 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 14238 | Indirect |
| Common shares without par value | 823 | Indirect |
Footnotes
F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of July 30, 2004.
F3: Reporting person disclaims beneficial ownership of all securities held by his son.
F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.